Compounds > aminopyrine, dexamethasone, phenylbutazone, thiamine, vitamin b12 drug combination
Page last updated: 2024-11-12
aminopyrine, dexamethasone, phenylbutazone, thiamine, vitamin b12 drug combination
Description
aminopyrine, dexamethasone, phenylbutazone, thiamine, vitamin B12 drug combination: 2 vial sets containing dexamethasone, phenylbutazone, vitamin B 12, aminopyrine & thiamine; also available in suppositories & tablets; used for treatment of rheumatism [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
PubMed CID | 11979810 |
MeSH ID | M0536820 |
Synonyms (7)
Synonym |
ambene |
aminopyrine, dexamethasone, phenylbutazone, thiamine, vitamin b12 drug combination |
vitamin b12, mixt. with 3-((4-amino-2-methyl-5-pyrimidinyl)methyl)-5-(2-hydroxyethyl)-4-methylthiazolium chloride, 4-butyl-1,2-diphenyl-3,5-pyrazolidinedione, 4-(dimethylamino)-1,2-dihydro-1,5-dimethyl-2-phenyl-3h-pyrazol-3-one and (11beta,16alpha)-9-fluo |
vitamin b12, dexamethasone, phenylbutazone, aminopyrine, and thiamine combination |
aminopyrine - dexamethasone - phenylbutazone - thiamine - vitamin b12 |
84020-72-4 |
trabit |
Research
Studies (6)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 4 (66.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 11.94
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 11.94 (24.57) | Research Supply Index | 2.20 (2.92) | Research Growth Index | 4.14 (4.65) | Search Engine Demand Index | 0.00 (26.88) | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 3 (37.50%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (62.50%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |